Contract facts
NONEMYBAITS MITO 384 RXN REAGENTS is a federal NONE award for Army Med Res Acq Activity held by Biodiscovery LLC. Estimated value $170K ($170K obligated). Current period of performance ends Feb 24, 2025. Last award drew 1 bidder. Place of performance: ANN ARBOR MI.
Recompete timing
PublicCurrent PoP ended Feb 24, 2025 (543 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HT942525F0102?
HT942525F0102 (Mybaits MITO 384 RXN reagents) is a Army Med Res Acq Activity award with a potential value of $170K, currently held by Biodiscovery LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is HT9425-25-F-0102?
HT9425-25-F-0102 is the dashed form of PIID HT942525F0102 (Mybaits MITO 384 RXN reagents), held by Biodiscovery LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded HT942525F0102?
Army Med Res Acq Activity awarded HT942525F0102 to Biodiscovery LLC (potential $170K).
Who is the incumbent on HT942525F0102?
Biodiscovery LLC is the incumbent. The current period of performance ends Feb 24, 2025.
When does Biodiscovery LLC’s HT942525F0102 come up for recompete?
SCOUT tracks a period-of-performance end of Feb 24, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.